Biortus Has Successfully Performed a Surface Plasmon Resonance (SPR) Fragment Screening for a Bromodomain-containing Protein

Since the purchase and arrival of a Biacore S200 on May 2018, our In Vitro Assays and Screening team has been busy with adapting, developing and incorporating the SPR technology into our Assays and Sc

04

2019

/

07

The Cryo Electron Microscope at Biortus Starts to Shine

In May 2019, the new Tecnai G2 TF20 cryo-electron microscope is up and operational at Biortus. As the first and only CRO company in China with cryo-EM capability, Biortus now offers a better and more

05

2019

/

06

Research Works Performed at Biortus Are Once Again Published in the World’s Top Journals

On 09 January 2019, the first membrane-associated protein structure solved by Biortus was published in one of the world’s top journal Nature Communications (5-year Impact Factor = 13.691).

19

2019

/

02

Congratulations on Rivastigmine Tartrate Project Passed the On-site Verification by a Listed Pharmaceutical Company

Biortus has passed the on-site verification of active pharmaceutical ingredient (API) Rivastigmine tartrate process development by a listed pharmaceutical company.

25

2018

/

07

< 123 >